Bipolar Depression Disease State Overview (1830)

Due to the evolving global coronavirus pandemic, AbbVie wanted to take this opportunity to thank you for your dedication to patient care.  Given the current restrictions related to in-person meetings, we wanted to provide an opportunity for nurse practitioners to attend a virtual educational seminar hosted by AbbVie Medical Affairs entitled: Bipolar Depression Disease State Overview. 

This one-hour, non-promotional program will be held on two separate occasions on Tuesday, June 30th at 11:30 AM CST and 6:30PM CST.  We hope that you will be able to join us for one of these discussions at a time that is convenient for you.  During this presentation, we will review bipolar depression disease state to include epidemiology and economic burden, comorbidities, etiology, diagnosis, diagnostic challenges, and treatment overview. We hope this presentation can provide useful insights into the disease state of bipolar depression.

 This presentation will be provided by two AbbVie Medical Science Liaisons, Micah Lands, PharmD (Little Rock, AR) and Margaret Martin, PharmD, BCPS (Smithfield, VA) who specialize in CNS/Psychiatry. 

Use the following link to access the presentation:

6:30 PM CST: https://engage.veeva.com/m.html?j=6570371023 (meeting ID 6570371023)

Please be sure to download the Veeva Engage app or open directly in your web browser from the link above (Chrome is preferred).  We recommend logging on several minutes prior to the start of the presentation to ensure you are able to join the meeting.  While not mandatory, please RSVP to micah.lands@allergan.com to confirm your planned attendance.